Back to Search
Start Over
Safety and Antitumor Activity of Anti-PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer.
Safety and Antitumor Activity of Anti-PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer.
- Source :
- Journal of Clinical Oncology; 12/1/2015, Vol. 33 Issue 34, p4015-4022, 13p
- Publication Year :
- 2015
Details
- Language :
- English
- ISSN :
- 0732183X
- Volume :
- 33
- Issue :
- 34
- Database :
- Supplemental Index
- Journal :
- Journal of Clinical Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 111081063
- Full Text :
- https://doi.org/10.1200/JCO.2015.62.3397